FameWave Reports Signing Of Clinical Collaboration Deal With Bristol Myers Squibb For Evaluation Of CM-24, Opdivo Combo In Patients With Non-Small Cell Lung Cancer; BZ NOTE: FameWave Will Be Acquired By Kitov Pharma
Benzinga Newsdesk